12.07.2015 Views

SK Gupta* et al. /International Journal Of Pharmacy&Technology

SK Gupta* et al. /International Journal Of Pharmacy&Technology

SK Gupta* et al. /International Journal Of Pharmacy&Technology

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>ISSN: 0975-766XReview ArticleAvailable Online Throughwww.ijptonline.comHERBAL AND HEPATOPROTECTIVE DRUGS ACTING ON PEPTIC ULCER AND LIVER DISEASE:A REVIEWS.K.<strong>Gupta*</strong> 1 and I.J.Singhvi 11 Pacific College of Pharmacy, Udaipur.Email: garg_s.kumar@yahoo.comReceived on 14-02-2011 Accepted on 24-02-2011ABSTRACTPeptic ulcer disease is an imb<strong>al</strong>ance b<strong>et</strong>ween offensive and defensive gastric factors. A bacterium c<strong>al</strong>ledHelicobacter pylori has been considered a major causative agent for gastric and duoden<strong>al</strong> ulcers. This is a majorcause of mort<strong>al</strong>ity in developing countries. Today, we have a bunch of herb<strong>al</strong> drugs that have very good potenti<strong>al</strong> totreat peptic ulcer and other gastrointestin<strong>al</strong> disorders both from tradition<strong>al</strong> knowledge and scientific data. Thisreview includes physiologic<strong>al</strong>, pathophysiologic<strong>al</strong> aspects related to peptic ulcer and liver disease and list of herb<strong>al</strong>drugs for treatment of gastrointestin<strong>al</strong> ulcers.Keywords: Herb<strong>al</strong> Drugs, Peptic ulcer, liver disease, Helicobacter pylori, <strong>et</strong>c.INTRODUCTIONPeptic ulcer disease is an imb<strong>al</strong>ance of aggressive gastric lumin<strong>al</strong> factors like acid and pepsin and defensive mucos<strong>al</strong>barrier function may be environment<strong>al</strong> and host factors contribute to ulcer formation by increasing gastric acidsecr<strong>et</strong>ion or weakening the mucos<strong>al</strong> barrier 1-3 . Elaborately, peptic ulcer disease is characterized by the imb<strong>al</strong>anceb<strong>et</strong>ween gastric offensive factors like acid, pepsin secr<strong>et</strong>ion, lipid per-oxidation, nitric oxide and defensive mucos<strong>al</strong>factors like mucin secr<strong>et</strong>ion, mucos<strong>al</strong> cell shedding, glycoprotein, proliferation & antioxidant enzymes like cat<strong>al</strong>ase,superoxide dismutase & glutathione levels 4. Peptic ulcers include both gastric and duoden<strong>al</strong> ulcers 5 . A bacteriumc<strong>al</strong>led Helicobacter pylori has been considered a major causative agent for gastric and duoden<strong>al</strong> ulcers.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 824


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Herb<strong>al</strong> Medicine is defined as branch of science in which plant based formulations are used to <strong>al</strong>leviate the diseases.It is <strong>al</strong>so known as botanic<strong>al</strong> medicine or phytomedicine. Lately phytotherapy has been introduced as more accuratesynonym of herb<strong>al</strong> or botanic<strong>al</strong> medicine. Recently, treatment of diseases with herb<strong>al</strong> medicine has been addressedas phytopharmacotherapy. Moreover, herb<strong>al</strong> medicin<strong>al</strong> products have been included lately in di<strong>et</strong>ary supplements.Early in the twenty century herb<strong>al</strong> medicine was a prime he<strong>al</strong>thcare system as antibiotics or an<strong>al</strong>gesics were notavailable. With the development of <strong>al</strong>lopathic systems of medicine, herb<strong>al</strong> medicine gradu<strong>al</strong>ly lost its popularityamong people and it was based on the fast therapeutic actions of synth<strong>et</strong>ic drugs. Almost a century has passed andwe have witnessed limitations of <strong>al</strong>lopathic systems of medicine. Lately herb<strong>al</strong> medicine has gained momentum andit is evident from the fact that certain herb<strong>al</strong> remedies peaked at par with synth<strong>et</strong>ic drugs.According to a study from U.S., 60-70% patients living in rur<strong>al</strong> areas are dependent on herb<strong>al</strong> medicine for their dayto day diseases 6 . Substances derived from the plants remain the basis for a large proportion of the commerci<strong>al</strong>medications used today for the treatment of heart disease, high blood pressure, liver disease, pain, asthma, and otherproblems.Sever<strong>al</strong> authors have reported favorable results with herb<strong>al</strong> drugs either in anim<strong>al</strong> or in human studies. Ginkgobiloba L., Echinacea purpurea L., Hypericum perforatum L. and Cimcifuga racemosa (L.) Nutt., were subjected toclinic<strong>al</strong> tri<strong>al</strong>s.Hepatoprotective drugs means the drugs that are used in the treatment of hepatic diseases; they improve the functionof hepatic cells while protecting them from further impairment.Silybum marianum L., the reputed hepatoprotective, has remained a golden standard in the treated of liver ailments.Sever<strong>al</strong> years have passed but status of this herb<strong>al</strong> drug remains unquestioned. In India, a study reported thatPicrorrhiza kurroa Royle. is more potent than Silybum marianum as hepatoprotective agent (however, this study isnot compl<strong>et</strong>e in <strong>al</strong>l aspects). If the results of the study were true, then more clinic<strong>al</strong> tri<strong>al</strong>s were warranted withPicrorrhiza kurroa.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 825


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Scope of the Herb<strong>al</strong> Therapy and Indian Herb<strong>al</strong> Mark<strong>et</strong>:Tradition<strong>al</strong> Indian practice held that certain drugs should be formulated through the addition of chosen substancesthat enhances bioavailability of anti-TB drug Rifampicin. Formulation of piperine with rifampicin will save the drugcounter effects.Herb<strong>al</strong> oriented pharmaceutic<strong>al</strong> companies are investing crores of rupees on researching, developing andpopularizing OTC remedies. India can be a major player in the glob<strong>al</strong> mark<strong>et</strong> for herb<strong>al</strong> product based medicines.Exports of herb<strong>al</strong> materi<strong>al</strong>s and medicines can jump from just Rs. 456 crore in 2000 to Rs.3000 crore in 2005 andwith a “grand strategic plan” exports can shoot to Rs.10,000 crore by 2010.The Significance of Qu<strong>al</strong>ity for Efficacy and Saf<strong>et</strong>y of Herb<strong>al</strong> DrugsThe efficacy and saf<strong>et</strong>y of any pharmaceutic<strong>al</strong> product is d<strong>et</strong>ermined by the compounds (desired and undesired)which it contains. The purpose of qu<strong>al</strong>ity control is to ensure that each dosage unit of the drug product delivers thesame amount of active ingredients and is, as far as possible, free of impurities. As herb<strong>al</strong> medicin<strong>al</strong> products arecomplex mixtures which originate from biologic<strong>al</strong> sources, great efforts are necessary to guarantee a constant andadequate qu<strong>al</strong>ity. By carefully selecting the plant materi<strong>al</strong> and a standardized manufacturing process the pattern andconcentration of constituents of herb<strong>al</strong> medicin<strong>al</strong> products should be kept as constant as possible as this is aprerequisite for reproducible therapeutic results.The major problem in qu<strong>al</strong>ity control is the batch to batch variations in the qu<strong>al</strong>ity of medicin<strong>al</strong> plants. This ismainly due to the existence of ecotype pharmacologic<strong>al</strong> variations in the case of many medicin<strong>al</strong> plants. Therapeuticv<strong>al</strong>ue of medicin<strong>al</strong> plants could differ depending on soil conditions, nutrition<strong>al</strong> status, climatic conditions, season<strong>al</strong>variations, diurn<strong>al</strong> variations and their association with other organisms.The digestion system is essenti<strong>al</strong> part of the human physiology. If the digestion is distorted due to any reason thenthe disease will appear. The peptic ulcer <strong>al</strong>so a disease which shows impaired digestion.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 826


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Peptic ulcer:Peptic ulcer is a sore area or erosion on the lining of the digestive system. If it is in the stomach, it is referred to as agastric ulcer. If it is in the duodenum (the part of the sm<strong>al</strong>l intestine just after the stomach), it is c<strong>al</strong>led a duoden<strong>al</strong>ulcer.It is the most common disease of upper G.I.T. system. It affects, 1 in 10 persons during life time 7 Peptic ulcers affect both men and women. 5–10% of people worldwide suffer from a peptic ulcer at least once in their lif<strong>et</strong>ime. Duoden<strong>al</strong> ulcers are more common than gastric ulcers and usu<strong>al</strong>ly occur in people aged fewer than 50.Gastric ulcers are more common in people aged over 50 8 .Mankind has lived with peptic ulcers since ancient times. He incubated and saw a vision; the god seemed to orderhis followers to seize and hold him, that he might incise his stomach. Acid neutr<strong>al</strong>ization was recognized as effectiv<strong>et</strong>reatment more than 12 centuries ago by Paulus Aeginata, who prescribed a mixture of Samian and Lemnian earthsand milk, not unlike the milk-antacid regimens of the mid-twenti<strong>et</strong>h century.Since then of course, considerable advances in understanding the pathogenesis and in the treatment of acidpepticconditions have occurred, culminating in the discovery of Helicobacter pylori and proton pump inhibitors. Wenow know that eradication of H. pylori effectively promotes he<strong>al</strong>ing of peptic ulcers and prevents their recurrence inmost cases, it is reasonable to conclude that the battle against the ravages of gastric acid is fin<strong>al</strong>ly turning in ourfactor 9 .Liver Disease 6 :Liver disease is a term for a collection of conditions, diseases, and infections that affect the cells, tissues, structures,or functions of the liver. Also c<strong>al</strong>led: Hepatic diseaseTypes of liver disease:a) Necrosisb) CirrhosisIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 827


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>c) Hepatitis – may be vir<strong>al</strong>, toxic or deficiency type.d) Hepatic failuree) Chemic<strong>al</strong> / Drug induced Hepatotoxicity: Gener<strong>al</strong>ly may be hepatitis, jaundice and carcinogenesis.f) Liver disorders due to impaired m<strong>et</strong>abolic function. Gener<strong>al</strong>ly the disorders associated with fat (liposis) andbilirubin (Jaundice) m<strong>et</strong>abolisms are very commonly seen.Signs and symptoms of the liver disease:Symptoms partly depend on the type and the extent of liver disease. In many cases, there may be no symptoms.Signs and symptoms that are common to a number of different types of liver disease include: Jaundice, or yellowingof the skin, Darkened urine, Nausea, Loss of app<strong>et</strong>ite, Unusu<strong>al</strong> weight loss or weight gain, Vomiting, Diarrhea,Light-colored stools, Abdomin<strong>al</strong> pain in the upper right part of the stomach, M<strong>al</strong>aise, or a vague feeling of illness,Gener<strong>al</strong>ized itching ,Varicose veins (enlarged blood vessels) ,Fatigue, hypoglycemia (low blood sugar), Low gradefever ,Muscle aches and pains, Loss of sex drive, DepressionLiver Anatomy and physiology: The liver produces and secr<strong>et</strong>es bile into the intestine where the bile assists with the digestion of di<strong>et</strong>ary fat. The liver helps purify the blood by changing potenti<strong>al</strong>ly harmful chemic<strong>al</strong>s into harmless ones. The sourcesof these chemic<strong>al</strong>s can be outside the body (for example, medications or <strong>al</strong>cohol), or inside the body (forexample, ammonia, which is produced from the break-up of proteins; or bilirubin, which is produced fromthe break-up of hemoglobin). The liver removes chemic<strong>al</strong>s from the blood (usu<strong>al</strong>ly changing them into harmless chemic<strong>al</strong>s) and then eithersecr<strong>et</strong>es them with the bile for elimination in the stool, or secr<strong>et</strong>es them back into the blood where they thenare removed by the kidneys and eliminated in the urine. The liver produces many important substances, especi<strong>al</strong>ly proteins that are necessary for good he<strong>al</strong>th. Forexample, it produces <strong>al</strong>bumin, the protein building-block of the body, as well as the proteins that cause bloodto clot properly.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 828


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong> Through a vast n<strong>et</strong>work of biochemic<strong>al</strong> reactions, the liver controls a major portion of the body's intern<strong>al</strong>environment. Some of its major functions include carbohydrate, fat, and protein m<strong>et</strong>abolism; formation andstorage of vitamins and miner<strong>al</strong>s; conjugation and excr<strong>et</strong>ion of steroid hormones; and d<strong>et</strong>oxification of drugsand other toxins.Problems associated with liver dysfunction can ultimately lead to serious illness such as hepatitis, cirrhosis, fattyliver, <strong>al</strong>coholic liver disease, and biliary cirrhosis. Symptoms and signs of liver disease include yellow discolorationof the skin and eyes, dark urine, gray, yellow or light colored stools, nausea, vomiting and/or loss of app<strong>et</strong>ite,vomiting of blood, bloody or black stools, abdomin<strong>al</strong> swelling, prolonged gener<strong>al</strong>ized itching, unusu<strong>al</strong> change ofweight, abdomin<strong>al</strong> pain, sleep disturbances, ment<strong>al</strong> confusion, and fatigueToday, as convention<strong>al</strong> medicine pursues a more integrated approach to managing disease, natur<strong>al</strong> products andselect herbs that influence liver function are being revisited and ev<strong>al</strong>uated for their over<strong>al</strong>l he<strong>al</strong>th promoting effects.In addition to the herb<strong>al</strong> treasure chest of ancient ayurveda offers a host of new phytochemic<strong>al</strong>s that can be used bothpreventively and clinic<strong>al</strong>ly to manage a spectrum of liver related imb<strong>al</strong>ances.Figure-1: LiverIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 829


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>UlcerEsophagitisEsophagusUlcerGastritisDuodenumUlcerFigure-2: StomachPathophysiology of Peptic Ulcer and Liver Disease 10 :The pathogenesis is multifactor. These ulcers never occur in his absence of gastric acid only about 50% of patientswith the disease secr<strong>et</strong>e excessive qu<strong>al</strong>ity of acid. This hyper secr<strong>et</strong>ion may be due to an increase pari<strong>et</strong><strong>al</strong> cell mass,excessive gastric release during me<strong>al</strong>s, enhanced sensitivity to gastrin or to other factors. The disease occurs as oftenin soci<strong>al</strong>ly disadvantaged manu<strong>al</strong> laborers.This disease is characterized by remissions and exacerbations relapse often occurs during spring and autumn.Relapses occur in 50 to 90% patients within a year of the first attack.Gastric ulcer:These ulcers occur with equ<strong>al</strong> frequency in man and women. The average age of ons<strong>et</strong> of gastric ulcers is b<strong>et</strong>ween40 to 55 years. The incidence is rising in the elderly due to the heavy use of aspirin and other non-steroid<strong>al</strong> antiinflammatorydrugs. Cigar<strong>et</strong>tes smoking and aspirin ingestion increase the risk of developing gastric ulcers.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 830


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Reason of gastric ulcer:1. Helicobacter pilori: Helicobacter Pylori is a curved or “s” shaped gram-negative bacillus with 4-6 lophotrichoussheathed flagella. Pylori is found primarily is the deep portions of the mucus gel layer that coats the gastric mucosaand b<strong>et</strong>ween the mucus gel layer and apic<strong>al</strong> mucos<strong>al</strong> epitheli<strong>al</strong> cells It pylori may adverse to the lumin<strong>al</strong> surface ofgastric epitheli<strong>al</strong> cells but does not invade the gastric mucosa 4Pathophysiology:H. Pylori produce a vari<strong>et</strong>y of proteins that appear to mediate or facilitate its damaging effect on his gastric mucosa.Urease produced by H. Pylori cat<strong>al</strong>yzed the hydrolysis of urea to ammonia and carbon dioxide.H. Pylori ureaseUrea Ammonia + CO 2Production of urease is required for gastric colorization by H. Pylori and may protect it. Pylori from theeffect of gastric acid, which norm<strong>al</strong>ly prevents gastric colorizations by either bacterium, hydroxide ion generated bythe equilibration of water with ammonia may contribute to gastric mucos<strong>al</strong> epitheli<strong>al</strong> damage.2. Decrement in gastric Defense:The stomach protects itself from damage by gastric acid through sever<strong>al</strong> mechanisms such as the presence ofintercellular tight junctions b<strong>et</strong>ween the gastric epitheli<strong>al</strong> cells, the presence of a mucin layer overlying the gastricepitheli<strong>al</strong> cells, the presence of prostaglandins in the gastric mucosa, and secr<strong>et</strong>ion of bicarbonate ions into themucin layer. Prostaglandins, E 2 and I 2 inhibit gastric acid secr<strong>et</strong>ion by a direct effect on the pari<strong>et</strong><strong>al</strong> cell mediated bythe EP 3 receptor 11 .THERAPY/TREATMENT:(A) Therapy for liver disease includes <strong>al</strong>lopathic and herb<strong>al</strong> drug treatment(1) Hepatoprotective <strong>al</strong>lopathic treatment: Specific drugs used in the management of liver disease:(i) Ursodeoxycholic acid (Ursodiol):IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 831


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Mechanism of action:Ursodeoxycholic acid decreases intestin<strong>al</strong> absorption and suppresses hepatic synthesis and storage of cholesterol.This is believed to reduce cholesterol saturation of bile and thereby <strong>al</strong>lowing solubilization of cholesterol-containingg<strong>al</strong>l stones. It has little effect on c<strong>al</strong>cified g<strong>al</strong>lstones or on radiolucent bile pigment stones and therapy is onlysuccessful in patients with a function<strong>al</strong> g<strong>al</strong>l bladder. Ursodeoxycholic acid, a relatively hydrophilic bile acid, is <strong>al</strong>sobelieved to protect the liver from the damaging effects of hydrophobic bile acids, which are r<strong>et</strong>ained in cholestaticdisorders. The immunomodulatory effects of ursodeoxycholic acid are believed to involve decreasedimmunoglobulin production by B lymphocytes, decreased interleukin-1 and interleukin-2 production by Tlymphocytes, decreased expression of hepatocyte cell surface membrane HLA class I molecules and possiblystimulation of the hepatocyte glucocorticoid receptor.Clinic<strong>al</strong> applications:Ursodeoxycholic acid has been used in the management of chronic hepatic diseases in humans such as primarybiliary cirrhosis, biliary disease secondary to cystic fibrosis, non<strong>al</strong>coholic steatohepatitis, idiopathic chronichepatitis, autoimmune hepatitis, primary sclerosing cholangitis, and <strong>al</strong>coholic hepatitis. However, its therapeuticefficacy in some of these disorders has not been firmly established.(ii) Penicillamine: Penicillamine is a degradation product of penicillin but has no antimicrobi<strong>al</strong> activity. It was firstisolated in 1953 from the urine of a patient with liver disease who was receiving penicillinMechanism of action:Penicillamine chelates sever<strong>al</strong> m<strong>et</strong><strong>al</strong>s including copper, lead, iron, and mercury, forming stable water solublecomplexes that are ren<strong>al</strong>ly excr<strong>et</strong>ed. It <strong>al</strong>so combines chemic<strong>al</strong>ly with cystine to form a stable, soluble, readilyexcr<strong>et</strong>ed complex. Although it usu<strong>al</strong>ly takes months to years for hepatic copper levels to decrease, clinic<strong>al</strong>improvement is often seen in Bedlington Terriers after only a few weeks suggesting the drug has other benefici<strong>al</strong>effects other than copper depl<strong>et</strong>ion. Penicillamine induces hepatic m<strong>et</strong><strong>al</strong>lothionein, which may bind and sequestercopper in a nontoxic form. It may <strong>al</strong>so have antifibrotic effects as it inhibits lysyl oxidase, an enzyme necessary forIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 832


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>collagen synthesis and directly binds to collagen fibrils, preventing cross-linking into stable collagen fibers.However, its efficacy as an antifibrotic agent in humans is doubtful and it has not been ev<strong>al</strong>uated in v<strong>et</strong>erinarymedicine. Penicillamine may have immunomodulatory effects and has been demonstrated to reduce IgM rheumatoidfactor in humans with rheumatoid arthritis. However, its mechanism of action in this disease remains uncertain.(iii) Other drugs include:Liver disease treatment will depend on the type and the extent of disease. For example, treating hepatitis B, hepatitisC, and hepatitis D may involve the use of medications such as the antivir<strong>al</strong> medication <strong>al</strong>pha interferon. Othermedications used to treat liver disease may include ribavirin, lamivudine, steroids, and antibiotics.Wilson’disease istreated by trientine or penicillamine. Other drugs are: Alpham<strong>et</strong>hyldopa, h<strong>al</strong>othane, INH (isoniazid), rifampicin,pyrazinamide, phenylbutazone, <strong>al</strong>lopurinol, chlorpromazine, m<strong>et</strong>hyltestosterone, erythromycin, glibenclamide.Side Effects:It will depend on the treatments used for the liver disease. Antibiotics may cause stomach ups<strong>et</strong> or <strong>al</strong>lergic reactions.Side effects of interferon include a flu-like illness with fever, and body aches.A liver transplant can cause many complications, including failure or rejection of the new liver. After a livertransplant, a person will need to take powerful anti-rejection medications for the rest of his or her life. Because thesemedications interfere with norm<strong>al</strong> immunes system functioning, they increase the person's risk for infections andcertain types of cancer.A person with hepatitis B, hepatitis C, or hepatitis D needs to be monitored for side effects and benefits during andafter interferon treatment. Alpha interferon treatment might be repeated if the disease flares up again. A person whohas received a liver transplant is checked for further disease, as well as for function of the new liver.Cirrhosis can lead to a number of complications, including liver cancer. In some people, the symptoms of cirrhosismay be the first signs of liver disease.(2) Herb<strong>al</strong> treatment:Classification:These are gener<strong>al</strong>ly classified into 3 categories without any strict delineation amongst them.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 833


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>1. Anti hepatotoxic agents: These gener<strong>al</strong>ly antagonise the effects of any hepatotoxin causing hepatitis or anyliver disorder or disease.2. Hepatotropic agents: These gener<strong>al</strong>ly support or promote the he<strong>al</strong>ing process of the liver. In practice thes<strong>et</strong>wo activities cannot be easily distinguished from each other.3. Hepatoprotective agents: These gener<strong>al</strong>ly prevent various types of liver affections prophilactic<strong>al</strong>ly. In gener<strong>al</strong>any hepatoprotective agent can act as an antihepatotoxic or hepatotropic agent but the vice versa is <strong>al</strong>waysnot true.Hepatoprotective Natur<strong>al</strong> Plants Treatmentt: Some of the crude drugs with activity against liver diseases arelisted in table no 1.Some Herb<strong>al</strong> Formulations Used In Liver Disorder:1. Liv-52: It is non-toxic hepatoprotective substance from The Him<strong>al</strong>aya Drug Co. Liv.52 can improve thesubjective condition and clinic<strong>al</strong> param<strong>et</strong>ers in patients with liver damage, in particular in <strong>al</strong>coholic liverdamage.2. LIMARIN®: Capsules and Suspension: It has a potent hepatoprotective and free radic<strong>al</strong> scavenging(antioxidant) action. LIMARIN® is developed from the active extract of the fruit of silybum marianum, orthe milk thistle. Basic<strong>al</strong>ly a European herb<strong>al</strong> product.3. Cirrhitin: Cirrhitin is a natur<strong>al</strong> medicine formulated specific<strong>al</strong>ly to treat Cirrhosis of the liver. Mark<strong>et</strong>ed byCCNOW.Some other polyherb<strong>al</strong> preparations such as Livex, HD-03, Hepatomed, Live 100 andHepatoguard with proven efficacy are <strong>al</strong>so use in different types of liver disorders.Ev<strong>al</strong>uation of Hepatoprotective activity: The liver function tests are employed for accurate diagnosis, to assess theseverity of the damage, to judge the prognosis and to ev<strong>al</strong>uate the therapy. The routinely performed liver functiontests (LFTS) and various models are presented in table no 2 and 3.(B) Therapy for peptic ulcerHerb<strong>al</strong> Drug Therapy of Peptic Ulcer Disease:IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 834


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Astrag<strong>al</strong>us: Astrag<strong>al</strong>us (Astrag<strong>al</strong>us membranaceus) has been used in Tradition<strong>al</strong> Chinese Medicine for thousands ofyears, often in combination with other herbs, to strengthen the body against disease. It contains antioxidants, whichprotect cells against damage caused by free radic<strong>al</strong>s, byproducts of cellular energy. Astrag<strong>al</strong>us is used to protect andsupport the immune system, for preventing colds and upper respiratory infections, to lower blood pressure, to treatdiab<strong>et</strong>es, and to protect the liver.Astrag<strong>al</strong>us has antibacteri<strong>al</strong>, anti-inflammatory, and diur<strong>et</strong>ic (helps eliminate fluid from the body) properties.It is som<strong>et</strong>imes used topic<strong>al</strong>ly for wounds. In addition, studies have shown that astrag<strong>al</strong>us has antivir<strong>al</strong> propertiesand stimulates the immune system, suggesting that it is indeed effective at preventing colds.In the United States, researchers have investigated astrag<strong>al</strong>us as a possible treatment for people whose immunesystems have been compromised by chemotherapy or radiation. In these studies, astrag<strong>al</strong>us supplements have beenshown to speed recovery and extend life expectancy. Research on using astrag<strong>al</strong>us for people with AIDS hasproduced inconclusive results.Recent research in China indicates that astrag<strong>al</strong>us may offer antioxidant benefits to people with severe formsof heart disease, relieving symptoms and improving heart function at low to moderate doses 12 .Barberry (Barberis vulgaris): Medicin<strong>al</strong> use of barberry dates as far back as ancient Egypt, and it has been used inIndian folk medicine to treat diarrhea, reduce fever, improve app<strong>et</strong>ite, relieve ups<strong>et</strong> stomach, and promote vigor aswell as a sense of well-being. Today, it is widely used for medicin<strong>al</strong> purposes in Iran, including for biliary disorders(such as g<strong>al</strong>lbladder disease) and heartburn.Barberry and goldense<strong>al</strong> (Hydrastis canadensis) are often used for similar medicin<strong>al</strong> purposes because bothherbs contain the chemic<strong>al</strong> berberine. Berberine has been shown to inhibit the growth of bacteria in test tubes, and<strong>al</strong>so may help the immune system function b<strong>et</strong>ter 12 .Bilberry (vaccinium miritilus): Bilberry has been used for centuries, both medicin<strong>al</strong>ly and as a food in jams andpies. It is related to the blueberry and is native to Northern Europe. Bilberry fruit contains chemic<strong>al</strong>s known asanthocyanosides, plant pigments that have excellent antioxidant properties. They scavenge damaging particles in theIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 835


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>body known as free radic<strong>al</strong>s, helping to prevent or reverse damage to cells. Antioxidants have been shown to helpprevent a number of long-term illnesses such as heart disease, cancer, and an eye disorder c<strong>al</strong>led maculardegeneration. Bilberry <strong>al</strong>so contains vitamin C, which is another antioxidant.Bilberry extracts are used in Europe to treat this condition, which occurs when v<strong>al</strong>ves in veins in the legs that carryblood to the heart are damaged. Some studies have reported improvements in symptoms, but most of the studieswere of poor design. on similar antioxidants, or from test tube and limited anim<strong>al</strong> studies 13 .C<strong>al</strong>endula (c<strong>al</strong>endula officin<strong>al</strong>is): the flower p<strong>et</strong><strong>al</strong>s of the c<strong>al</strong>endula plant (c<strong>al</strong>endula officin<strong>al</strong>is), or marigold, havebeen used for medicin<strong>al</strong> purposes since at least the 12th century. C<strong>al</strong>endula is native to mediterranean countries butis now grown as an ornament<strong>al</strong> plant throughout the world. It is important to note, however, that not <strong>al</strong>l householdplants c<strong>al</strong>led marigold are members of the c<strong>al</strong>endula family.C<strong>al</strong>endula contains high amounts of flavonoids, plant-based antioxidants that protect the body against celldamagingfree radic<strong>al</strong>s. Researchers are not sure what active ingredients in c<strong>al</strong>endula are responsible for its he<strong>al</strong>ingproperties, but it appears to have anti-inflammatory, antivir<strong>al</strong>, and antibacteri<strong>al</strong> effects 13 .Cat's claw (Uncaria tomentosa): Cat's claw (Uncaria tomentosa) is a woody vine native to the Amazon rainforestand other tropic<strong>al</strong> areas of South and Centr<strong>al</strong> America. It is named after the hook-like thorns that grow <strong>al</strong>ong its vine.The bark and root of this herb have been used by South Americans going back to the Inca civilization to treat avari<strong>et</strong>y of he<strong>al</strong>th problems including arthritis, stomach ulcers, inflammation, dysentery, and fevers. It was <strong>al</strong>so usedas a form of birth control.Test tube studies indicate that cat's claw may stimulate the immune system, help relax the smooth muscles(such as the intestines), dilate blood vessels (helping lower blood pressure), and act as a diur<strong>et</strong>ic (helping rid thebody of excess water). It <strong>al</strong>so has antioxidant properties, helping rid the body of particles known as free radic<strong>al</strong>s thatdamage cells 14 .Cayenne (Capsicum annuum): Cayenne pepper is an important spice, particularly in Cajun and Creole cooking,and in the cuisines of Southeast Asia, China, Southern It<strong>al</strong>y, and Mexico. Cayenne has <strong>al</strong>so been used in tradition<strong>al</strong>IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 836


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Indian Ayurvedic, Chinese, Japanese, and Korean medicines as an or<strong>al</strong> remedy for digestive problems, poor app<strong>et</strong>ite,and circulatory problems. It has <strong>al</strong>so been used as a topic<strong>al</strong> remedy for arthritis and muscle pain. Today, topic<strong>al</strong>preparations of capsaicin are used in the United States and Europe primarily to relieve pain associated withconditions such as arthritis and shingles (Herpes zoster). Capsaicin is <strong>al</strong>so a key ingredient in many person<strong>al</strong> defensesprays 15 .Evening primrose oil (Oenothera bienensis): Evening primrose has served as food and medicine at throughoutpoultices from the plant for bruises and hemorrhoids. European s<strong>et</strong>tlers took the root back to England history, oftenfor ups<strong>et</strong> stomach and respiratory infections. Native Americans ate the boiled, nutty-flavored root, and used leaf andGermany, where it was introduced as food and became known as German rampion because it grew as a crawlingvine. The plant was <strong>al</strong>so a Shaker medicine, sold commerci<strong>al</strong>ly 15 .Garlic (Allium sativum): Garlic has been used as both food and medicine in many cultures for thousands of years,dating as far back as the time that the Egyptian pyramids were built. Later, gravediggers in early 18 th century Francedrank a concoction of crushed garlic in wine they believed would protect them from the plague that killed manypeople in Europe. More recently, during both World Wars I and II, soldiers were given garlic to prevent gangrene.Today garlic is used to help prevent heart disease, including atherosclerosis (plaque buildup in the arteries that canblock the flow of blood and possibly lead to heart attack or stroke), high cholesterol, high blood pressure, and toimprove the immune system. Garlic may <strong>al</strong>so protect against cancer 15 .Liquorice (Glycyrrhiza glabra ): Liquorice (Glycyrrhiza glabra ) is a flavorful herb that has been used in food andmedicin<strong>al</strong> remedies for thousands of years. Also known as "swe<strong>et</strong> root," liquorice root contains a compound that isroughly 50 times swe<strong>et</strong>er than sugar. Liquorice root has been used in both Eastern and Western medicine to treat avari<strong>et</strong>y of illnesses ranging from the common cold to liver disease. This herb has long been v<strong>al</strong>ued as a demulcent(soothing, coating agent) and expectorant (rids phlegm and mucous from the respiratory tract) and continues to beused by he<strong>al</strong>th care profession<strong>al</strong>s today to relieve respiratory ailments (such as <strong>al</strong>lergies, bronchitis, colds, sor<strong>et</strong>hroats, and tuberculosis), stomach problems 16 .IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 837


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>D<strong>al</strong>bergia mon<strong>et</strong>aria (Linn.): The lyophilized aqueous extract (LAE) of D. mon<strong>et</strong>aria has significantantiulcerogenic activity and inhibited gastric ulcers lesions induced by pylorus ligature, <strong>et</strong>hanol and hypothermicrestraint stress. To identity the antiulcerogenic mechanism of action of LAE of D. mon<strong>et</strong>aria, the effect of LAE onprostaglandin E 2 synthesis and on the characteristic (pH volume and tot<strong>al</strong> acid) content of gastric juice.The protective effect of the LAE on induced gastric lesion might be because of synergistic effect increasedPhI 2 synthesis and antagonism of H 2 histamine and b<strong>et</strong>a adrenergic receptors, reducing gastric acid secr<strong>et</strong>ion,increase PGE 2 synthesis results n increase protection and antagonism of H 2 histamine and b<strong>et</strong>a receptor reducedaggressive factors against the gastric mucosa 22 .Mikania cordata root: The effect of m<strong>et</strong>ahanolic fraction of Mikania cordata root <strong>al</strong>coholic extract investigated forits possible ulcer protective activity in m<strong>al</strong>e Sprague dawley rats. Or<strong>al</strong> administration of this extract significantlyprevented the occurrence of water immersion stress induced gastric ulcer in dose responsive manner.The extract <strong>al</strong>so dose dependently inhibited gastric ulcers induced by <strong>et</strong>hanol aspirin and phenylbutazone.The gastric mucus secr<strong>et</strong>ion in norm<strong>al</strong> as well as stress and <strong>et</strong>hanol induced ulcerates anim<strong>al</strong> increased dosedependently.Therefore, M. cordata next extract possess antiulcer activity and that the observed activity may be due tomodulation of defensive factor through an improvement of gastric cytoprotection 23 .Ocimum sanctum L. (Labiatae): O. sanctum found to posse’s significant antiulcer activity against aspirin,indom<strong>et</strong>hacin, <strong>al</strong>cohol, histamine, reserpine, serotonin and stress induced ulceration experiment<strong>al</strong> anim<strong>al</strong> model.Significant inhibition <strong>al</strong>so observed gastric secr<strong>et</strong>ion and aspirin-induced gastric ulceration in pylorus-ligated rats.The lipoxygenase inhibitory histamine antagonistic and antisecr<strong>et</strong>ery effect of oil could probably have contributedtowards antiulcer activity O. sanctum fixed oil may be considered to be a drug natur<strong>al</strong> origin which posses both antiinflammatoryand antiulcer activity 24 .Centella asiatica (Linn.): Extract of C. asiatica inhibited significantly gastric ulceration induced by cold andrestraint stress in Charles fosters rats, antiulcer activity of plant extract compared with famotidine (H 2 antagonist)IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 839


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>and sodium v<strong>al</strong>proate (antiepileptic). Plant <strong>al</strong>coholic extract, formotidine and sodium v<strong>al</strong>proate showed a dosedependent reduction of a gastric ulceration 25 .Dombeya bu<strong>et</strong>tneri The effects of an aqueous extract of leaves of D. b<strong>et</strong>ween on gastric acid secr<strong>et</strong>ion and <strong>et</strong>hanolinduced gastric mucos<strong>al</strong> damage studied in rats. Gastric acid secr<strong>et</strong>ion measure by continuous perfusion in ur<strong>et</strong>haneanaesth<strong>et</strong>izedIntragastric perfusion with extract caused significant reduction in bas<strong>al</strong> and histamine stimulated gastric acidsecr<strong>et</strong>ion. Pr<strong>et</strong>reatment with extract <strong>al</strong>so reduced the extent of gastric mucos<strong>al</strong> damage induced by or<strong>al</strong> <strong>et</strong>hanol (75%V/V) but have no effect on mucus secr<strong>et</strong>ion.Therefore, consumption of an extract of the leaves of D. bu<strong>et</strong>tneri may be benefici<strong>al</strong> prevention andtreatment of peptic ulcer disease 26 .Neurolaena lobata: The hexane fraction (H X F) chloroform fraction (CIF) and aqueous fraction (H 2 OF) fractions ofa hydro <strong>al</strong>coholic extract (HE) of N. lobata aeri<strong>al</strong> parts were investigation there ability to prevent ulceration gastricmucosa. The pylorus ligature experiment demonstrated that HE, H X F and CIF fraction changed significantly thegastric juice param<strong>et</strong>ers such as pH v<strong>al</strong>ue (increase to 5.4, 4.9. and 4.8 respectively) and acid output (decreases by4.6, 5.3 and 6.2 (--) 4th respectively) and gastric content (increased by 400, 410 and 390 mg, respectively) inanim<strong>al</strong>s.M. lobata present significant antiulcer effect when assessed in this ulcer, induced models by increasedactivity of defensive mechanism of stomach, such as prostaglandin synthesis and mucus production 27 .Ezanatia chlorantha: Antiulcer action of novel protoberberine type <strong>al</strong>k<strong>al</strong>oid [7,8-dihdro-8 –Hydroxy p<strong>al</strong>matine (1)],obtained from bark of E.chlorantha using the HCl <strong>et</strong>hanol, absolute <strong>et</strong>hanol and pylorus ligation techniques. Thehe<strong>al</strong>ing effect on chronic ac<strong>et</strong>ic acid induced gastric ulcer that, dose dependently inhibited the formation of gastriculcer induced by HCl/ <strong>et</strong>hanolThe significant inhibition of pylorus-ligated ulcers occurs at gastric acid concentration previously known toinduce severe gastric ulceration in rats.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 840


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>The prophylactic antiulcer effect is associated with enhanced mucus production, which is an important factor inmechanism of the loc<strong>al</strong> he<strong>al</strong>ing process of chronic gastric ulcers 28 .C<strong>al</strong>otropis procera: The role of chloroform fraction of C. procera root extract on different experiment<strong>al</strong> ulcermodels in rats investigated. The extract demonstrates significant antiulcer activity against aspirin, indom<strong>et</strong>hacin<strong>et</strong>hanol, indom<strong>et</strong>hacin + <strong>et</strong>hanol or stress- induced ulcerations.Significant inhibition of gastric secr<strong>et</strong>ary volume and tot<strong>al</strong> acidity in pylorus ligated rats observed to occurwith extract. It <strong>al</strong>so observed that root extract significantly inhibited arachidonic acid m<strong>et</strong>abolism induced bysoybean lipoxygenase.The result suggest that the antiulcer activity of exact might be attributable to the inhibition of 5-lipoxygenose 29Chinese cinnamon: Two active compounds prevent serotonin-induced ulcerogenesis in rats isolate from Chinesecinnamon (the stem bark of cinnamomum cassia) and identified as 3-(2-hydroj-phenyl)- propanoic acid and it O-glucoside. The former compound, administered or<strong>al</strong>ly or parenter<strong>al</strong>ly to rats as remarkably low dose, <strong>al</strong>so inhibitedgastric ulcer induced by other ulcerogens such as phenylbutazone, <strong>et</strong>hanol and water immersion stress.3- (2-hydroxyphenyl)-propanoic acid hardly inhibited secr<strong>et</strong>ion of gastric acid but promote gastric bloodflow, attributable to potentiation of defensive factors through the improvement the circulatory disorder and gastriccytoprotection 30 .Turkish: The anti-helicobacter pylori of extracts and fraction obtain from seven Turkish plants, which are used infolk medicine for the treatment of gastric disorders including peptic ulcer, study against are standard strain and eightclinic<strong>al</strong> isolates of pylori by using the agar dilution m<strong>et</strong>hod. Flower of cistus laurifolius and spartium jumceum,cones of cedrus libani, herbs and flowers of centaurea solstit<strong>al</strong>is ssp. Solstit<strong>al</strong>is, fruits of momordica charanta,herbaceous parts of sambucus ebulus, and flowering herbs of hypericum perforatum ev<strong>al</strong>uated in study.Ocimum sanctum (linn.): The antiulcerogenic property of Ocimum sanctum linn (OSL) study on pyloric ligated andpyloric ligated and aspirin treated rats. The aquous extract of OSL reduce the ulcer index tree and tot<strong>al</strong> acidity anacidity and chronic administration.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 841


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>Seven days pr<strong>et</strong>reatment with drugs increase the mucosa secr<strong>et</strong>ion <strong>al</strong>so. So, OSL extract has antiulcerogenicproperty against experiment<strong>al</strong> ulcers 31 .Chamomile (Matricaria recutita): Chamomile has been used in connection with colic, gastritis, indigestion andheartburn, peptic ulcer, ulcerative colitis and wound he<strong>al</strong>ing 19 .Active constituents: The flowers of chamomile provide 1-2% volatile oils containing α-bisabolol, α-bisabolol oxidesA and B, and matricin , bioflavonoids apigenin, luteolin and querc<strong>et</strong>in. These active ingredients contribute tochamomiles anti-inflammatory, antispasmodic and smooth muscle relaxing action, particularly in gastrointestin<strong>al</strong>tract 32 .Benincasa HispidaExtract : M<strong>et</strong>ahanolic fruit extractModel : Inbred M<strong>al</strong>e wistar rats Swiss <strong>al</strong>bino miceAntiulcer studies: HCl/ <strong>et</strong>hanol induced gastric lesions indom<strong>et</strong>hacin-HCl/<strong>et</strong>hanol model Aspirin pylorus ligationmodel.Rabdosia trichocarpa: A diterpane, trichorabd<strong>al</strong> a from Rabdosia trichocarpa, show a very strong in vitroantibacteri<strong>al</strong> activity against helicobacter pylori. Regard to antibacteri<strong>al</strong> activity of extract and constituents treatmentof gastritis is due to suppression of pylori since the extract of R. trichocarpa particularly inhibit the growth of H.pylori. It is promising native herb treatment for patient with gastric complaints including gastric ulcer caused by H.pylori 33 .Neem: The antiulcer effect of aqueous extract of leaves of neem tree investigate on rats exposed to 2-hr. coldrestraint stress or given <strong>et</strong>hanol or<strong>al</strong>ly for in extracts administer in doses of 10,40 or 160 mg level/kg body weighteither as single or five dose treatment regimens.Means dose-dependently reduced gastric ulcers severity in rats subjected to stress and decreased <strong>et</strong>hanolproduced gastric mucos<strong>al</strong> damage. The extract appeared to prevent most cell deregulation and to increase the amountIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 842


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>of advent gastric mucus in stressed anim<strong>al</strong>s these effects may explain at least in parts, the mode of antiulcer action ofneem 34 .Turmeric (Curcuma longa): An <strong>et</strong>hanol extract of turmeric study on rats for its ability to inhibit gastric secr<strong>et</strong>ionand to protect gastroduoden<strong>al</strong> mucosa against the injuries caused by pyloric ligation hypothermic restraint stressindom<strong>et</strong>hacin reserpine and cysteamine administration and cystodestructive agent including 82% <strong>et</strong>hanol, 0.6 HCl,0.2 M NaOH and 25% NaCl. An or<strong>al</strong> dose of 500mg/kg of the extract produced significant antiulcerogenic activityin rats subjected to hypothermic restraint stress, pyloric ligation and indom<strong>et</strong>hacin and reserpine administration theextract has a highly significant protective effect against cystodestructive agents 35Tectona grandis: 70% of <strong>et</strong>hanol extracts of its defatted trunk bark and wood chips show significant antiulcerogeniceffect against experiment<strong>al</strong> ulcers in <strong>al</strong>bino rats and guinea pigs. Napthaquinone and lapachol active principlelapachol 5mg/mg or<strong>al</strong>ly twice daily for three days have antiulcerogenic effect on experiment<strong>al</strong> gastric and duoden<strong>al</strong>ulcer in rats and guinea pigs. Its significant antisecr<strong>et</strong>ery activity and reduction in tot<strong>al</strong> carbohydrate, protein rationgastric juice in pylorus ligated rats 36 .Bupleurum f<strong>al</strong>catum L. (Roots): Crude saponin fraction from B. f<strong>al</strong>catum showed weak antiulcerogenic activity inpylorus lighted ulcer model. Polysaccharides which are obtained by Bupleurum posse’s potent antiulcer activityagainst HCl <strong>et</strong>hanol induced lesions in mice. Acidic polysaccharide fraction from roots of B. f<strong>al</strong>catum and studied itseffect an HCl-<strong>et</strong>hanol, <strong>et</strong>hanol and water immersion stress induced gastric lesions in mice and pylorus lighted ulcersin rats.Dose of 50-200 mg/kg inhibit the formation of gastric lesion induced by necrotizing agent such as HCl<strong>et</strong>hanol and <strong>et</strong>hanol in dose dependent manner and ulcer induced by water immersion stress or pylorus ligation 36 .Pistacia lentiseus (Mastic): Mastic is the concr<strong>et</strong>e resinous exudates obtained from tree Pistacia lentiseus. Action oninduced gastric and duoden<strong>al</strong> ulcer by pyloric ligation, aspirin, phenylbutazone, reserpine and restraint and coldstress. Decrease of free acidity in 6 th pylorus ligated rats. Cytoprotective effect given against rod <strong>et</strong>hanol in rats. ItIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 843


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>may form complex with protein and produce cytoprotective layer, which protect the gastric mucosa against Injuriousagent bite s<strong>al</strong>t and pepsin 37 .Pinax ginseng: Pinax cinseng show a dose dependent inhibition of HCl/<strong>et</strong>hanol, induced ulcer in mice. GL-4 fromthe leaves of P. ginseng at doses of 50 to 200mg/kg inhibited the formation of gastric lesions induced by necrotizingagent such as HCl/<strong>et</strong>hanol 37 .GL-4 <strong>al</strong>so inhibits the formation of gastric ulcers induced by water immersion stress indom<strong>et</strong>hacin or pylorusligation. P ginseng reduces both gastric acidity and pepsin activity of juice 38 .Andographis Aeri<strong>al</strong> Parts (Andographis paniculata): Tradition<strong>al</strong>ly used for a vari<strong>et</strong>y of ailments including liverdisorders and has <strong>al</strong>so been shown to protect against toxin - induced hepatotoxicity. The diterpenes of andrographiswere shown to increase glutathione (GSH), which may decrease suspectibility of the tissue to oxidative damage 39 .Hellebore Root (Picrorhiza Kurroa): Used tradition<strong>al</strong>ly in Ayurveda for centuries as a gener<strong>al</strong> liver tonic and forliver cleansing, hepatitis, biliousness, fevers and poisoning. In a randomized, double-blind, placebo-controlled tri<strong>al</strong>in patients with acute vir<strong>al</strong> hepatitis, hellebore root(375 mg/3 times daily for 14 days) led to rapid f<strong>al</strong>l in serumbilirubin levels toward norm<strong>al</strong> range and quicker clinic<strong>al</strong> recovery with no side effects. Current evidence <strong>al</strong>soindicates hellebore root protects against <strong>al</strong>cohol-induced hepatotoxicity 39Ginger Rhizome (Zingiber officin<strong>al</strong>): Tradition<strong>al</strong>ly used to promote digestion. Ginger has been found to have astimulatory effect on gastric secr<strong>et</strong>ions and has m<strong>et</strong>abolic circulatory enhancing effects which reinforces th<strong>et</strong>herapeutic activity of other herbs 19,20 .Embelia Fruit (Embelia officin<strong>al</strong>): Tradition<strong>al</strong>ly used for hepatic conditions and liver rejuvenation 40 .Trailing Eclipta Leaf and Root (Eclipta Alba): Tradition<strong>al</strong>ly used as a cholagogue (aids bile secr<strong>et</strong>ion) anddeobstruent (removes function<strong>al</strong> obstructions in the body) in hepatic enlargement, for jaundice, and other ailments ofthe liver and g<strong>al</strong>l bladder.Two coumestans, wedelolactone and dem<strong>et</strong>hyl-wedelolactone were isolated as the main active principles present intrailing eclipta. Both constituents showed anti-hepatotoxic activity in assays using liver enzyme-induced cytotoxicityIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 844


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>in cultured rat hepatocytes. These constituents <strong>al</strong>so showed a significant stimulatory effect on liver cell regeneration.Evidence suggests that trailing eclipta exerts its protective action through a reduction in GSH depl<strong>et</strong>ion 40 .Indian G<strong>al</strong>l Fruit (Termin<strong>al</strong>ia chebula): Tradition<strong>al</strong>ly used in chronic diarrhea and dysentery, flatulence, vomiting,colic, and enlarged spleen and liver. In a study conducted on rabbits, Indian g<strong>al</strong>l fruit had a hypocholesterolemiceffect on cholesterol inducedhypercholesterolemia 40Chicory Seed (Cichorium intybus): Tradition<strong>al</strong>ly used for hepatic conditions and liver rejuvenation and has shownprotective effects in mice with high levels of liver damaging enzymes 40 .Long Pepper Fruit (Piper longum): Piperine, an active <strong>al</strong>k<strong>al</strong>oid constituent, has been shown to exert a significantprotection against liver toxicity induced by tert-butyl hydro peroxide and carbon t<strong>et</strong>rachloride by reducing in bothvitro and vivo lipid peroxidation by decreasing the reduction of GSH 40 .Arjuna Myrob<strong>al</strong>an Bark (Termin<strong>al</strong>ia arjuna): The powdered bark is tradition<strong>al</strong>ly used as a diur<strong>et</strong>ic and gener<strong>al</strong>tonic in cases of cirrhosis of the liver 41 .Amla Fruit (Emblica officin<strong>al</strong>is): Tradition<strong>al</strong>ly used for enlarged liver and for liver revit<strong>al</strong>izing 42 .Spreading Hog Weed Whole Plant (Boerhaavia diffusa): Tradition<strong>al</strong>ly used for hepatic disorders and for intern<strong>al</strong>inflammation 43 .Phylanthus Aeri<strong>al</strong> Parts (Phyllanthus niruri): The fresh root is tradition<strong>al</strong>ly given in peptic ulcer 44 .SUMMARY AND CONCLUSION:Peptic ulcer is common gastro intestin<strong>al</strong> disorder and includes gastro esophage<strong>al</strong> reflux peptic ulcer and ZEsyndrome.It is usu<strong>al</strong>ly arising due to imb<strong>al</strong>ance in aggressive (gastric juice, pepsin production, H. pylori, <strong>al</strong>cohol,NSAID’S) and defensive factor (endogenous prostaglandin, gastri<strong>al</strong> mucos<strong>al</strong> barriers). To treat this disease twocategories of the drugs are used: Synth<strong>et</strong>ic drugs, Herb<strong>al</strong> drugs. Herb<strong>al</strong> drugs in case of this disease play animportant role owing to various protective and curing effects on stomach. These are not only effective in the pepticulcer but <strong>al</strong>so show different associated activities.• Antistress activity: Abiexs pindrowIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 845


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>• Increase mucin secr<strong>et</strong>ion and life span of mucosa cell: Bacopa monniera.• Increase PG production: Flueggea microcarpa.• Cytoprotective action: Zingiber officin<strong>al</strong>e, capsaicin.• Acid neutr<strong>al</strong>izing capacity: Beninecosa lispida.• Decrease volume acidity of gastric juice: Garcina Cambogia.• Antibacteri<strong>al</strong> action against H. pylori: Rabdosia trichocarpas.• H + K + ATPase activity inhibitor: Kampo formulation.• Anti histamines: Atractylodes lancea.• Inhibition of 5- Lipoxygenase: C<strong>al</strong>otropis procera.The drugs from the plant origin play very important role to treat the peptic ulcer.To conclude it may be said that herb<strong>al</strong> drugs have provided us with potent weapons like atropine, codeine,taxol, vincristine and vinblastine. In the modern scenario, diseases are becoming drug-resistant and scientists arestudying possible roles of plant based drugs for screening life saving drugs. The herb<strong>al</strong> system of medicine is a fullyfledged system of medicine and it cannot be ruled out as quackery. Backing up this system is the fact that ancientfindings and documentation have through the centuries provided us with leads on the development of life-savingdrugs.Liver disease appears to be on the increase. Part of this increase may be due to our frequent contact withchemic<strong>al</strong>s and other environment<strong>al</strong> pollutants. The amount of medicine consumed has increased greatly withresulting dangers to the liver. The liver, the d<strong>et</strong>oxifying factory in the body, has become an increasingly overworkedorgan. While those who smoke, abuse <strong>al</strong>cohol and drugs and live in severely polluted environments are at greatestrisk, we <strong>al</strong>l suffer some threat of damage or disease to the liver.Sever<strong>al</strong> hundred plants have been examined for use in a wide vari<strong>et</strong>y of liver disorders. Just handfuls havebeen fairly well researched. The latter category of plants include: Silybum marianum (milk thistle), Picrorhizakurroa (kutkin), Curcuma longa (turmeric), Camellia sinensis (green tea), Chelidonium majus (greater celandine),Glycyrrhiza glabra (licorice), and Allium sativa (garlic). Silybum marianum, Picrrorhiza kurroa, Andrographispaniculata, Phyllanthus niruri, and Eclipta Alba are proven hepatoprotective medicin<strong>al</strong> herbs, which have shownIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 846


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>genuine utility in liver disorders. These plants are used widely in hepatotprotective preparations and extensivestudies have been done on them.It can be concluded that knowledge of Alternative and Complementary Systems of Medicines like Ayurveda,botany, pharmacognosy and phytochemistry, biochemistry, <strong>et</strong>hno pharmacology and toxicology is integr<strong>al</strong> part ofherb<strong>al</strong> medicine.Table-1: Some of the crude drugs with activity against liver diseases.Plant name Synonyms Family Origin Chemic<strong>al</strong> constituents UseSilybumAsteraceaemarianumTaraxacumofficin<strong>al</strong>eCichoriumintybusSolanumnigrumGlychyrrhizaglabraWilkstroemia indicaCurcum<strong>al</strong>ongaCarduusmarianus,marian<strong>et</strong>histleindigenousto theMediterranean region,NorthAfrica &WesternAsiaDandelion Asteraceae All parts ofthenorthernhemisphereCichoryBlacknightshadeAradonindica,wilkstromiaCurucuma,turmeric,Indian saffronCompositae(asteraceae)SolanaceaeLeguminosaeThymelaeaceaeZingiberaceaeflavonolignansincluding silybin,silydianin, andsilychristine, Silybumseeds <strong>al</strong>so containb<strong>et</strong>aine (a provenhepatoprotector) andessenti<strong>al</strong> fatty acids,Bitter constituents lik<strong>et</strong>araxecerin andtaraxcin, sesquiterpenelactones, phenolic acid,inulin, Kbitter glucoside,Cichorinsolamargine,andsolasonin<strong>et</strong>riterpene saponin,known as glycyrrhizin,glucose, sucrose, bitterprinciple glycyramarinresin, aspargin and fatdicoumarin,daphnor<strong>et</strong>inDiarylhepatonoidsincluding Curcumin,Curcuminoids volatileoil, starchliver disease,dyspepsia, disorders ofbiliary system,hepatoprotective andin chronicinflammatory hepaticdisordersHepatic & biliarydisorders, kidneystones, remedy forjaundice diur<strong>et</strong>ic, tonicliver diseases, liverprotection,chlorpromazineinducedhepaticdamageliver disorders,hepatoprotectiveactivity, cirrhosis ofthe liver emollient,diur<strong>et</strong>ic, antiseptic,and laxativeproperties,Antimicrobi<strong>al</strong>,antioxidants, cytotoxicproperties,antiulcerogenicactivityanti-vir<strong>al</strong> liver diseasepromote theregeneration of livercellshepatitis B activator ofprotein kinase Cprotect anim<strong>al</strong> liversas anti-inflamatorydrugIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 847


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>TephrosiapurpureaFumariaofficin<strong>al</strong>isPeumusboldusChionanthusvirginicusAndrograhispaniculataElipta <strong>al</strong>baPhyllanthusniruri/amarusbasterdindigo, hoarypeasharpunkhaFumatoryBoldoFringe tree,old man’sbeardK<strong>al</strong>megEcliptaarecta, ecliptaprostataPhyllanthusemblica,jonesiansocaFabaceaePapaveraceaeMonimiaceeOleaceaeAcanthaceaeCompositae(asteraceaeEuphorbiaceaeEurope,Mediterranean,MiddleEast, buthas nowbecome aweed <strong>al</strong>lover theworldChile andother southAmericanregionsSouthernparts ofNorthernAmericaAndrographis leaves,as well asthe freshjuice of thewholeandrographis planttephrosin, deguelin andquerc<strong>et</strong>inAlk<strong>al</strong>oids, flavonoidsAlk<strong>al</strong>oids, volatile oils,flavonols and theirglycosidesSaponins, ligninglycosideandrographolide, abicyclic diterpenoidlactone and K<strong>al</strong>meghin(upto 2.5%).andrographolide,deoxyandrographolideand neoandrographolide<strong>al</strong>k<strong>al</strong>oid known asecliptin, nicotin,glucosideflavonoids and<strong>al</strong>k<strong>al</strong>oidstreatment of liver andspleen diseasesprotective actionagainst carbont<strong>et</strong>rachloride and D-g<strong>al</strong><strong>al</strong>actosaminepoisoning.Biliary & dyspepticdisorders, especi<strong>al</strong>lyspastic discomfort ofthe GIT, the g<strong>al</strong>lbladder& bile ductsDyspepsia, spasticcomplaints. It is th<strong>et</strong>radition<strong>al</strong> antheminticin Chile. It is <strong>al</strong>so usedin pharmaceutic<strong>al</strong>slimming mixturesg<strong>al</strong>l stones, hepatitis,jaundice &gener<strong>al</strong> tonic, diur<strong>et</strong>ic& febrifuge.minor wounds, sores,bruises, inflammationAntipyr<strong>et</strong>ic, bacteri<strong>al</strong>dysentery, arrestingdiarrhea and in upperrespiratory infectionstonsillitis, pharyngitis,laryngitis, pneumonia,tuberculosis, andpyelonephritis herpes,skin infections, and inhelminthic (parasitic)infections, terminatingpregnancies.Vir<strong>al</strong> hepatitis, liverdisorders, skin- andhair care, improvescomplexion, c<strong>al</strong>m themind, memorydisorders, swollenglands, visiong<strong>al</strong>l stones, hepatitis,jaundice & otherailments associatedwith poor liverfunction). gener<strong>al</strong>tonic, diur<strong>et</strong>ic &febrifugeIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 848


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>PicrorrhizakurroraIndiangentian, kutkiScrophulariaceaeirridoid bittersubstances picroside,picroside and kutkosidev<strong>al</strong>uable bitter tonic,antiperiodic, febrifugeand stomachic andlaxative jaundicepotenti<strong>al</strong>hapatoprotectantTable-2: Liver function tests (LFTS) for Hepatoprotective Activity.Type of Ev<strong>al</strong>uationTestsAbnorm<strong>al</strong>ities of bile pigments and bile s<strong>al</strong>ts • Serum tot<strong>al</strong> direct and indirect bilirubin.excr<strong>et</strong>ion tests• Urine bile s<strong>al</strong>ts, bile pigments and urobilinogenSerum enzymes assays SGOT (AST )• SGPT (AST )• Alk<strong>al</strong>ine phosphatase (ALP) and if necessary• γ – Glutamyl transpeptidase (γ-GT)• Other enzymesChanges in plasma protein testsThymol turbidity test.• D<strong>et</strong>ermination of tot<strong>al</strong> proteins, <strong>al</strong>bumin globulinsTable-3: Various models for Hepatoprotective Activity.ModelsIn vitro m<strong>et</strong>hodDiscriptionHepatocytes are isolated by using in-situ under aseptic condition and placed in chilledHEPES (N-2-hydroxy<strong>et</strong>hylpiperazine-N-2-<strong>et</strong>hanesulphonic acid).• These isolated hepatocytes than exposed to test samples and toxins like CCl4,thioac<strong>et</strong>amide, <strong>et</strong>hanol and parac<strong>et</strong>amol <strong>et</strong>c.• After a specified time period the degree of toxicity or protection is assessed by viabilitytests (Trypan blue dye exclusion m<strong>et</strong>hod) and enzyme levels such as SGOT and SGPT.Ex vivo m<strong>et</strong>hod• In this m<strong>et</strong>hod after compl<strong>et</strong>ion of preselected in vivo test protocol hepatocytes areisolated and the percentage of viable cells and biochemic<strong>al</strong> param<strong>et</strong>ers are d<strong>et</strong>ermined asliver function tests.• These m<strong>et</strong>hods are somewhat b<strong>et</strong>ter correlated to clinic<strong>al</strong> models than in vitro or in vivom<strong>et</strong>hods.These are of two types.In vivo m<strong>et</strong>hod•Based on bile param<strong>et</strong>ers• Based on serum param<strong>et</strong>ersExperiment<strong>al</strong> ratmodels• CCl4 model• Thioac<strong>et</strong>amide model• D-G<strong>al</strong>actosamine model• Parac<strong>et</strong>amol model• Chloroform model• Ethanol modelIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 849


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>REFERENCES:1. Davenport, H.W., N Engl J Med, 1967, 276, 1307–1312.2. Flemström, G., Turnberg, L. A., Gastroduoden<strong>al</strong> defence mechanisms. In: Isenberg JI, Johansson C, eds.Clinics in Gastroenterology, 13th edn. London, Philadelphia, Toronto: WB Saunders Company, 1984: 327–54.3. Grossman, M.I., Gastroenterology 1978, 75, 524–26.4. Prabha, T., Dorababu, M., Goel, S., Agarw<strong>al</strong>, P.K., Singh, A., Joshi, V.K. Goel, R.K., IJEB. 2009, 47/08,649-659.5. Marsh<strong>al</strong>l, B.J., Warren, J.R., Lanc<strong>et</strong> 1984, 1, 1311–1315.6. http://www.zentiva.com/default.aspx/en/consumers/glossary/group-indication7. Blaser, M.J. “Gastroenterology”. 1987, vol.93: 317-83.8. Soll, A.H. and Berglindn, T. Physiology of isolated gastric glands and pareit<strong>al</strong> cell; receptor and effectorsregulating function “Physiology of the gastro Intestin<strong>al</strong> Tract. 2 nd edition, 1987, 883-908.9. Laurance, D.R. and Ben<strong>et</strong>te, D.M. Gastro Intestin<strong>al</strong> System I : Stomach and Oesophagus, In : “Clinic<strong>al</strong>Pharmacology”. 7 th edition, 1992, 517-24.10. Golan, D.E., Tashjian, A.H., Armstrong, E.J., Armstrong, A.W. (EDs.), Principles of Pharmacology ThePathophysiologic Basis of Drug Therapy, Lippincott Williams & Wilkins, USA 2008, pp. 811- 823.11. Goodman’s, Gillman’s In: The Pharmacologic<strong>al</strong> basis of therapeutics. 10 th edition, 2001, 1005-1008.12. Madkarni, K.M. Indian materia medica. 1989, vol. I : 87-88.13. Sharma, P.V., Treatment of Parinamasula, in Cakradatta : A Treatise on principles and practices ofAyurvedic medicine. 1994, 249.14. Datta, G.K., Sairam, K., Priyambada, S., Debnath, P.K., Goel, R.K. Indian Journ<strong>al</strong> of experiment<strong>al</strong> Biology.2002, vol. 40:173-1177.15. Misra, B.S., Vaisya, R.L. Varanasy, Chaukhambha Sanskrit santhan. 1969, 605-606.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 850


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>16. Rege, N.N, Thatte, U.M., Dahanukar, S.A., Adaptogenic Properties of six rasayana herbs used in ayurvedmedicine, Phytotherpy. 1999, 275-291.17. Sany<strong>al</strong>, A.K., Panday, B.L., Goel, R.K., The effect of tradition<strong>al</strong> preparation of nigella sativa, onexperiment<strong>al</strong> ulcers and gastric secr<strong>et</strong>ion. J Ethno Pharmacol. 1982, 79-89.18. Goel, R.K., Govinda Das D., Sanay<strong>al</strong>, A.K., Effect of Asparagus racemosus powder on changes induced byulcerogenic agents on dissolved mucosubstance in gastric juice, Indian J. of gastroenterol. 1985, vol. IV:249-251.19. Yoshikawa, M., Hatakeyama S., Taniguchi K., Matuda H. Yamahara J. 6-Gin gesulhonic acid, a new antiulcerprinciple and ginger glycolipids A,B and C, three new Monoacyldig<strong>al</strong>actosylglycerols, from Zingiberrhizome originating in Taiwan, Chemic<strong>al</strong> Pharmaceutic<strong>al</strong> Bull<strong>et</strong>in. 1992, vol.40: 2239-2240.20. Yamanara, J., Mochizuki, M., Rang, H.Q., Matsuda, H., Fujimura, H., The antiulcer effect in rats of gingerconstituents. J. Ethnopharmacol. 1988, vol. XXIII: 299-304.21. Sen, T., Ghosh, T.K., Chudhuri, A.K. “Studies on the mechanism of anti inflammatory and anti-ulcer activityof pluchea indica-probable involvement -of 5-lipooxygenose pathway” life Sci. 1993, vol. 52(8): 737-43.22. Cota, R.H, Grassi, K.D.M., Spadari, B.R.C., Souza, B.A.R. “Antiulceregenic mechanisms of a lyophilizedaqueous extract of D<strong>al</strong>bergia mon<strong>et</strong>aria in rats, mice and guinea-pigs” J. Pharma. Pharmacol. 1999, vol. 51(6): 735-40.23. Bishayee, A, Chtterjee, M. “Protective effects of Mikania Cordata root extract against physic<strong>al</strong> and chemic<strong>al</strong>factors-induced gastric erosions on experiment<strong>al</strong> anim<strong>al</strong>s” Plant Med 1994, vol. 60 (2) : 110-3.24. Singh, s. Majumdar, D.K. “Ev<strong>al</strong>ution of the gastric antulce activity of fixed oil of Ocimum sanctum (HolyBasil)” J. Ethanopharmacol. 1999, vol. 65 (1) : 13-9.25. Chatterjee,T.K., Chakraborty, A.,Pathak, M. sengupta, G.C. “Effects of plant extract Centella asiatica (Linn)on cold restraint stress ulcer in rats”. Indian J. exp Biol. 1992, vol.xxx (10): 889-891.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 851


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>26. Okawari, O.O., Ettarh, R.R., Akpogomeh, B.A., Eteng, M.U. “Gastric anti-secr<strong>et</strong>ory and anti-ulceroeniceffects of Dombeya bu<strong>et</strong>theri in rats” J Ethnopharmacol. 2000, vol. 71(1-2): 315-9.27. Goel, R.K., Chakrabarti, A. Sany<strong>al</strong> A.K. the effect of Biologic<strong>al</strong> variables on the anti-ulcerogenic effect onNeurolaena lobata, Planta medica. 1985, vol. II: 85-88.28. Goel, R.K. Effect of Ezanatia Chlorentha on gastric secr<strong>et</strong>ion and ulceration: a cepermentol and clinic<strong>al</strong>study P.H.D. thesis submitted to, Banaras Hindu University. 1983.29. Sen, T., Basu, A., Chaudhuri, A.K. “Studies on the possible mechanism of the gastric mucos<strong>al</strong> protection byC<strong>al</strong>otropis procera- involvement of 5-lipoxygenase pathway”. Fundam Clin Pharmacol. 1998, (1): 82-7.30. Tanka, S., Yoon, Y.H, Fukui, H., Tabata, M., Akira, T., Okano, Okano, Iwai, M., Iga, Y., Yokoyama, K,“Antiulcerogenic compounds isolated from Chinease cinnamon” Planta med. 1989, vol. 55 (3):245-8.31. Madanl<strong>al</strong>, S. Das, D.M., De, K., Raj, D., Roy, G., Chaudhuri, S.b., Sahana, C.C., Chowdhuri, M.K.“Ocimum sancum linna study on gastric ulceration and gastric secr<strong>et</strong>ion in rats” Indian J. Physiol pharmacol.1993,(1) :91-2.32. Della, Loggia, R., Tubaro, A “The role of flavonoids in antinflammatory activities of chamomile”. Plantamed. 1983, vol. 49:67 to 63.33. Kadota, S., Basn<strong>et</strong>, P., Ishii, E., Tamura, T., Namba, T. “Antbacteri<strong>al</strong> activity of trichorabd<strong>al</strong> A fromRabdosia trichocarpa against Helicobacter pylori”. Zentr<strong>al</strong>bl Bakteriol. 1997,289 (1):63-7.34. Garg, G.P., Migam, S.K., Ogle, C.W. “The gastric antiulcer effects of he leaves of he neem tree “. Plantamed. 1993, vol.59 (3): 215-7.35. Rafatullah, S., Tariqu, M., Al-Yahya, M.A. Mossa, J.S, Ageel, A.M. “Ev<strong>al</strong>uation of turmeric for gastric andduoden<strong>al</strong> antiulcer activity in rats”. J. Ethnopharmacol. 1999, vol. 89 (1): 25-34.36. Parmar, N.S. “Antiulcer drugs of herb<strong>al</strong> origin” XIII Annu<strong>al</strong> conference of Indian “Pharmacologic<strong>al</strong> soci<strong>et</strong>y.1997, 16-20.37. Z<strong>al</strong>kow, C.H., Hydson C.C., Pauris,G. Medicin<strong>al</strong> and Aromatic Plant Abstrac. 1984, 17-19.IJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 852


S.K.<strong>Gupta*</strong> <strong>et</strong> <strong>al</strong>. /Internation<strong>al</strong> Journ<strong>al</strong> <strong>Of</strong> Pharmacy&<strong>Technology</strong>38. Vanisree, A.T., Shyam<strong>al</strong>adevi, C.S. Current science. 1997, vol. 73: 684-686.39. Luper S. A review of plants used in the treatment of liver diseases: Part 1. Altern Med Rev 1998; 3: 410-21.40. D, Jia J, Brinkhaus B, Hahn EG. Herb<strong>al</strong> products for liver diseases: A therapeutic ch<strong>al</strong>lenge for the newmillenmium. Hepat<strong>al</strong>ogy 1999; 30; 1099-104.41. Kawashima, K., Kondoh, K., Ochi, Y., Oka, M. “Effect of Arjuna Myrob<strong>al</strong>an on liver defensive factors inrats”. Nippon Yakurigaku Zasshi. 1991, vol.98 (2) : 73-82.42. Germano, M.P., Sanogo, R., Guglielmo, M., De, Posqu<strong>al</strong>e, R., Crisafi, G., Bisignano, G. “Effects of Emblicaofficin<strong>al</strong> extracts on Hepatitis”. J. Ethnopharmacol. 1998, vol. 59 (3): 167-72.43. Vailati A, Aristia L, Sozze E, Milani F, Inglese V, G<strong>al</strong>enda P, <strong>et</strong> <strong>al</strong>. Randomized open study of the doseeffectrelationship of a short course of Boerhaavia diffusa in patients with vir<strong>al</strong> or <strong>al</strong>coholic hepatitis.Fitoterapia 1993; 64: 219-31.44. Srivastava S, Srivastava AK, Patnaik GK, Dhawan BN. Effect of Phyllanthus niruri on liver regeneration inrats. Fitoterapia.Corresponding Author:S.K.<strong>Gupta*</strong> 1Email:garg_s.kumar@yahoo.comIJPT | March-2011 | Vol. 3 | Issue No.1 | 824-853 Page 853

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!